147 related articles for article (PubMed ID: 2515268)
1. Hypocalcemia complicating deferoxamine therapy in an infant with parenteral nutrition-associated aluminum overload: evidence for a role of aluminum in the bone disease of infants.
Klein GL; Snodgrass WR; Griffin MP; Miller NL; Alfrey AC
J Pediatr Gastroenterol Nutr; 1989 Oct; 9(3):400-3. PubMed ID: 2515268
[TBL] [Abstract][Full Text] [Related]
2. Aluminum in parenteral products: medical perspective on large and small volume parenterals.
Klein GL
J Parenter Sci Technol; 1989; 43(3):120-4. PubMed ID: 2499667
[TBL] [Abstract][Full Text] [Related]
3. Metabolic bone disease associated with total parenteral nutrition.
Klein GL; Coburn JW
Adv Nutr Res; 1984; 6():67-92. PubMed ID: 6439013
[TBL] [Abstract][Full Text] [Related]
4. Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content.
Vargas JH; Klein GL; Ament ME; Ott SM; Sherrard DJ; Horst RL; Berquist WE; Alfrey AC; Slatopolsky E; Coburn JW
Am J Clin Nutr; 1988 Oct; 48(4):1070-8. PubMed ID: 3138907
[TBL] [Abstract][Full Text] [Related]
5. Multifactorial low remodeling bone disease during cyclic total parenteral nutrition.
de Vernejoul MC; Messing B; Modrowski D; Bielakoff J; Buisine A; Miravet L
J Clin Endocrinol Metab; 1985 Jan; 60(1):109-13. PubMed ID: 3917265
[TBL] [Abstract][Full Text] [Related]
6. Deferoxamine therapy of bone aluminum accumulation in renal dialysis patients.
Nutr Rev; 1985 Apr; 43(4):103-5. PubMed ID: 3923410
[No Abstract] [Full Text] [Related]
7. Metabolic bone disease in home total parenteral nutrition.
McCullough ML; Hsu N
J Am Diet Assoc; 1987 Jul; 87(7):915-20. PubMed ID: 3110249
[TBL] [Abstract][Full Text] [Related]
8. Successful high-dose calcium treatment of aluminum-induced metabolic bone disease in long-term home parenteral nutrition.
Lidor C; Schwartz I; Freund U; Gazit D
JPEN J Parenter Enteral Nutr; 1991; 15(2):202-6. PubMed ID: 2051559
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of 1,25-dihydroxyvitamin D in children receiving parenteral nutrition with reduced aluminum content.
Klein GL; Horst RL; Alfrey AC; Slatopolsky E
J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):93-6. PubMed ID: 3920379
[TBL] [Abstract][Full Text] [Related]
10. Reduction of bioavailability of aluminium in neonatal parenteral nutrition solutions by prior complexation in the dosage form.
Hayes P; Martin TP; Pybus J; Hunt J; Broadbent RS
J Parenter Sci Technol; 1992; 46(5):169-75. PubMed ID: 1432456
[TBL] [Abstract][Full Text] [Related]
11. Total parenteral nutrition and its effects on bone metabolism.
Klein GL; Coburn JW
Crit Rev Clin Lab Sci; 1994; 31(2):135-67. PubMed ID: 7917007
[TBL] [Abstract][Full Text] [Related]
12. Calcium metabolism in children during long-term total parenteral nutrition: the influence of calcium, phosphorus, and vitamin D intakes.
Larchet M; Garabédian M; Bourdeau A; Gorski AM; Goulet O; Ricour C
J Pediatr Gastroenterol Nutr; 1991 Nov; 13(4):367-75. PubMed ID: 1779310
[TBL] [Abstract][Full Text] [Related]
13. Complications associated with total parenteral nutrition in infants with short bowel syndrome.
Nousia-Arvanitakis S; Angelopoulou-Sakadami N; Metroliou K
Hepatogastroenterology; 1992 Apr; 39(2):169-72. PubMed ID: 1353049
[TBL] [Abstract][Full Text] [Related]
14. Bone disease associated with total parenteral nutrition.
Klein GL; Targoff CM; Ament ME; Sherrard DJ; Bluestone R; Young JH; Norman AW; Coburn JW
Lancet; 1980 Nov; 2(8203):1041-4. PubMed ID: 6107676
[TBL] [Abstract][Full Text] [Related]
15. Metabolic bone disease of total parenteral nutrition.
Klein GL
Nutrition; 1998 Jan; 14(1):149-52. PubMed ID: 9437701
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of total parenteral nutrition using Vamin and Aminosyn as protein base in critically ill preterm infants.
Sankaran K; Berscheid B; Verma V; Zakhary G; Tan L
JPEN J Parenter Enteral Nutr; 1985; 9(4):439-42. PubMed ID: 3928917
[TBL] [Abstract][Full Text] [Related]
17. Plasma Aluminum Concentrations in Pediatric Patients Receiving Long-Term Parenteral Nutrition.
Courtney-Martin G; Kosar C; Campbell A; Avitzur Y; Wales PW; Steinberg K; Harrison D; Chambers K
JPEN J Parenter Enteral Nutr; 2015 Jul; 39(5):578-85. PubMed ID: 24743391
[TBL] [Abstract][Full Text] [Related]
18. Parenteral drug products containing aluminum as an ingredient or a contaminant: response to Food and Drug Administration notice of intent and request for information. ASCN/A.S.P.E.N. Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions.
JPEN J Parenter Enteral Nutr; 1991; 15(2):194-8. PubMed ID: 1904955
[TBL] [Abstract][Full Text] [Related]
19. Aluminum in parenteral products: analysis, reduction, and implications for pediatric TPN.
Rabinow BE; Ericson S; Shelborne T
J Parenter Sci Technol; 1989; 43(3):132-9. PubMed ID: 2499670
[TBL] [Abstract][Full Text] [Related]
20. Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition.
Goodman WG; Misra S; Veldhuis JD; Portale AA; Wang HJ; Ament ME; Salusky IB
Am J Clin Nutr; 2000 Feb; 71(2):560-8. PubMed ID: 10648272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
